Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
2.720
+0.070 (2.64%)
At close: Apr 2, 2026, 4:00 PM EDT
2.660
-0.060 (-2.21%)
After-hours: Apr 2, 2026, 7:11 PM EDT
Context Therapeutics Employees
Context Therapeutics had 12 employees as of September 30, 2025. The number of employees did not change since the number was reported on December 31, 2024.
Employees
12
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,010,301
Market Cap
249.91M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 12 | 0 | - |
| Dec 31, 2024 | 12 | 7 | 140.00% |
| Dec 31, 2023 | 5 | -4 | -44.44% |
| Dec 31, 2022 | 9 | 8 | 800.00% |
| Dec 31, 2020 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Coherus Oncology | 147 |
| Voyager Therapeutics | 141 |
| Adagene | 138 |
| Alector | 103 |
| Editas Medicine | 87 |
| Orchestra BioMed Holdings | 86 |
| Keros Therapeutics | 78 |
CNTX News
- 3 days ago - Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer - GlobeNewsWire
- 13 days ago - Context Therapeutics Reports Full Year 2025 Operating and Financial Results - GlobeNewsWire
- 17 days ago - Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026 - GlobeNewsWire
- 7 weeks ago - Context Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 months ago - Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting - GlobeNewsWire
- 5 months ago - Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results - GlobeNewsWire
- 5 months ago - Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer - GlobeNewsWire